#62 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
If pharmacists become part of the cannabis care team, patients would benefit from professional drug interaction checks, standardized dosing advice, and a layer of safety oversight that most dispensaries currently cannot provide.
The role of pharmacists in cannabis care remains largely absent despite cannabis being one of the most widely used therapeutic agents in the country, creating a significant gap in patient safety, drug interaction screening, and dosing guidance. Integrating pharmacists into cannabis dispensing and oversight could dramatically improve outcomes by ensuring patients receive the same level of professional medication management they expect from every other prescription. From a clinical standpoint, the absence of pharmacist involvement represents one of the most glaring inconsistencies in how we regulate therapeutic substances in the United States.
“I have seen thousands of patients harmed not by cannabis itself but by the absence of trained clinical professionals guiding its use, and pharmacists are the most obvious missing piece in this system.”
💊 Cannabis remains a striking outlier in medicine: widely recommended, widely used, and almost entirely outside the pharmacist’s scope of practice. In my clinic, I regularly see patients on complex medication regimens who have never once had a professional screen their cannabis products for drug interactions. Pharmacists are trained specifically to catch what doctors and dispensary staff may miss, from CYP450 enzyme interactions to contraindicated combinations with blood thinners and seizure medications. ️ The current system essentially asks patients to be their own pharmacists, which we would never accept for opioids, benzodiazepines, or even statins. Bringing pharmacists into cannabis policy is not about adding bureaucracy but about giving patients the standard of care they deserve.
Have thoughts on this? Share it: